Deborah Birx
Amministratore Delegato presso ARMATA PHARMACEUTICALS, INC.
Patrimonio netto: 2 M $ in data 30/04/2024
Posizioni attive di Deborah Birx
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 11/07/2023 | - |
| Amministratore Delegato | 11/07/2023 | - | |
Nanolive SA
 Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Deborah Birx
Precedenti posizioni note di Deborah Birx
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INNOVIVA, INC. | Direttore/Membro del Consiglio | 09/03/2021 | 10/07/2023 |
| Independent Dir/Board Member | 09/03/2021 | 10/07/2023 |
Formazione di Deborah Birx
| Houghton College | Undergraduate Degree |
| Pennsylvania State University College of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Svizzera | 2 |
Posizioni
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| ARMATA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Nanolive SA
Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Deborah Birx
- Esperienza